SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017427
Filing Date
2017-08-11
Accepted
2017-08-11 16:40:29
Documents
81
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-10q_20170630.htm 10-Q 2225357
2 EX-31.1 isco-ex311_10.htm EX-31.1 8787
3 EX-31.2 isco-ex312_9.htm EX-31.2 9304
4 EX-32.1 isco-ex321_8.htm EX-32.1 5501
5 EX-32.2 isco-ex322_7.htm EX-32.2 6202
  Complete submission text file 0001564590-17-017427.txt   9913672

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isco-20170630.xml EX-101.INS 2436151
7 XBRL TAXONOMY EXTENSION SCHEMA isco-20170630.xsd EX-101.SCH 70755
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20170630_cal.xml EX-101.CAL 45274
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20170630_def.xml EX-101.DEF 333759
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20170630_lab.xml EX-101.LAB 489125
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20170630_pre.xml EX-101.PRE 467727
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 171025681
SIC: 2834 Pharmaceutical Preparations